Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -1.12% is 95% above its 5-year average of -22.46%, near the high end of its 5-year range (-188.89%–30.98%).
80.52% above its 12-month average of -5.75%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 5.96%.
OPERATING MARGIN
-1.12%
OPERATING MARGIN AVG TTM
-5.75%
OPERATING MARGIN AVG 3Y
-18.93%
OPERATING MARGIN AVG 5Y
-22.46%
OPERATING MARGIN AVG 10Y
-15.44%
OPERATING MARGIN AVG 15Y
-23.87%
OPERATING MARGIN AVG 20Y
-32.37%
CURRENT VS TTM AVG
+80.52%
CURRENT VS 3Y AVG
+94.08%
CURRENT VS 5Y AVG
+95.01%
CURRENT VS 10Y AVG
+92.75%
CURRENT VS 15Y AVG
+95.31%
CURRENT VS 20Y AVG
+96.54%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 496 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
BioLife Solutions, Inc.
Market Cap
$1.89B
Operating Margin
-1.12%
TTM Avg
-5.75%
3Y Avg
-18.93%
5Y Avg
-22.46%
Market Cap
$1.87B
Operating Margin
-873.87%
TTM Avg
-1020.17%
3Y Avg
-1557.98%
5Y Avg
-1038.65%
Market Cap
$1.83B
Operating Margin
2.61%
TTM Avg
3.43%
3Y Avg
5.52%
5Y Avg
6.07%
Market Cap
$1.95B
Operating Margin
-4454.21%
TTM Avg
-3427.90%
3Y Avg
-2683.37%
5Y Avg
-2097.52%
Market Cap
$1.96B
Operating Margin
-18.48%
TTM Avg
-24.30%
3Y Avg
-28.12%
5Y Avg
-27.55%
Market Cap
$1.78B
Operating Margin
-737.04%
TTM Avg
-849.82%
3Y Avg
-849.82%
5Y Avg
-849.82%
Market Cap
$1.78B
Operating Margin
-651.67%
TTM Avg
-787.38%
3Y Avg
-968.58%
5Y Avg
-820.03%
Market Cap
$2.00B
Operating Margin
-5.12%
TTM Avg
-2.62%
3Y Avg
-10.04%
5Y Avg
-13.46%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioLife Solutions, Inc. (BLFS) | $1.89B | -1.12% | -5.75% | -18.93% | -22.46% |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.87B | -873.87% | -1020.17% | -1557.98% | -1038.65% |
| Astrana Health, Inc. (ASTH)vs › | $1.83B | 2.61% | 3.43% | 5.52% | 6.07% |
| Absci Corporation (ABSI)vs › | $1.95B | -4454.21% | -3427.90% | -2683.37% | -2097.52% |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.96B | -18.48% | -24.30% | -28.12% | -27.55% |
| Azenta, Inc. (AZTA)vs › | $1.97B | -3.49% | -3.57% | -5.95% | -5.03% |
| Generate Biomedicines, Inc. (GENB)vs › | $1.78B | -737.04% | -849.82% | -849.82% | -849.82% |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.78B | -651.67% | -787.38% | -968.58% | -820.03% |
| AxoGen, Inc. (AXGN)vs › | $2.00B | -5.12% | -2.62% | -10.04% | -13.46% |
| Fortrea Holdings Inc. (FTRE)vs › | $2.01B | 0.41% | -3.56% | 0.15% | -1.31% |
Gross Margin
64.5%
Operating Margin
-1.1%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 5.96% |
| 2026-03-31 | 0.10% |
| 2025-12-31 | 30.98% |
| 2025-09-30 | -0.32% |
| 2025-06-30 | -65.47% |
| 2025-03-31 | -5.09% |
| 2024-12-31 | -40.48% |
| 2024-09-30 | -5.10% |
| 2024-06-30 | -6.62% |
| 2024-03-31 | -17.88% |
| 2023-12-31 | -40.19% |
| 2023-09-30 | -65.65% |
| 2023-06-30 | -36.35% |
| 2023-03-31 | -36.08% |
| 2022-12-31 | -113.52% |
| 2022-09-30 | -28.81% |
| 2022-06-30 | -188.89% |
| 2022-03-31 | -22.00% |
| 2021-12-31 | -46.23% |
| 2021-09-30 | -33.01% |
| 2021-06-30 | -14.60% |
| 2021-03-31 | -5.82% |
| 2020-12-31 | -32.21% |
| 2020-09-30 | -11.05% |
| 2020-06-30 | 0.44% |
| 2020-03-31 | 3.04% |
| 2019-12-31 | -7.00% |
| 2019-09-30 | -11.69% |
| 2019-06-30 | 11.15% |
| 2019-03-31 | 9.81% |
| 2018-12-31 | 19.12% |
| 2018-09-30 | 22.58% |
| 2018-06-30 | 24.81% |
| 2018-03-31 | 3.66% |
| 2017-12-31 | -6.96% |
| 2017-09-30 | -1.09% |
| 2017-06-30 | -13.34% |
| 2017-03-31 | -19.61% |
| 2016-12-31 | -27.87% |
| 2016-09-30 | -53.29% |
| 2016-06-30 | -80.10% |
| 2016-03-31 | -80.58% |
| 2015-12-31 | -77.18% |
| 2015-09-30 | -79.44% |
| 2015-06-30 | -77.23% |
| 2015-03-31 | -77.33% |
| 2015-01-31 | -60.12% |
| 2014-09-30 | -70.33% |
| 2014-06-30 | -73.26% |
| 2014-03-31 | -17.87% |
| 2013-12-31 | -12.44% |
| 2013-09-30 | -5.07% |
| 2013-06-30 | -3.56% |
| 2013-03-31 | 8.90% |
| 2012-12-31 | -15.02% |
| 2012-09-30 | -8.84% |
| 2012-06-30 | -27.94% |
| 2012-03-31 | -21.45% |
| 2011-12-31 | -26.01% |
| 2011-09-30 | -39.80% |
| 2011-06-30 | -41.75% |
| 2011-03-31 | -74.37% |
| 2010-12-31 | -56.02% |
| 2010-09-30 | -54.52% |
| 2010-06-30 | -83.70% |
| 2010-03-31 | -76.78% |
| 2009-12-31 | -92.93% |
| 2009-09-30 | -96.76% |
| 2009-06-30 | -243.91% |
| 2009-03-31 | -194.48% |
| 2008-12-31 | -0.06% |
| 2008-09-30 | 799169.15% |
| 2008-06-30 | -213.95% |
| 2008-03-31 | -176.50% |
| 2007-12-31 | 45970.05% |
| 2007-09-30 | -185752129.23% |
| 2007-06-30 | 220797270.99% |
| 2007-03-31 | 216571724.14% |
| 2006-12-31 | -247.73% |
| 2006-09-30 | -319.29% |
| 2006-06-30 | -285.20% |
| 2006-03-31 | -229.20% |
| 2005-12-31 | -86.42% |
| 2005-09-30 | -98.41% |
| 2005-06-30 | -97.55% |
| 2005-03-31 | -138.31% |
| 2004-12-31 | 1.11% |
| 2004-09-30 | -99.09% |
| 2004-06-30 | -162.45% |
| 2004-03-31 | -163.98% |
| 2003-12-31 | -242.79% |
| 2003-09-30 | -316.76% |
| 2003-06-30 | -426.72% |
| 2003-03-31 | -144.75% |
| 2002-12-31 | -74.82% |
| 2002-09-30 | -152.22% |
